RxDoctor Payments DataLook up a doctor →

Maria Martinez Colon, MD

Dermatology · San Juan, PRNPI 1073554390

Payments from drug & device makers

$1,424,607in general payments, 2019–2025

Across 544 payments — averaging $2618.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1.3M
  • Eli Lilly Export S.A. Puerto Rico Branch$53K
  • Amgen$25K
  • Pfizer$6K
  • E.r. Squibb & Sons, L.L.C.$743
  • Eli Lilly$400
  • plus $579 from 3 others
$24,761in research payments, 2019–2025

Across 3 payments — averaging $8253.54 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Eli Lilly Export S.A. Puerto Rico Branch$22K
  • Eli Lilly$3K

What the payments were for

  • Consulting fees$1,57528%
  • Food & beverage$4,09872%
  • Education$501%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,424,607 in reported general payments places this provider in the 95th percentile of 108 dermatology providers in Puerto Rico.

See all dermatology providers in Puerto Rico

Medicare billing

Part B allowed, 2024
$34,311
Medicare patients
70
Services billed
371

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Betamethasone Dipropionate190$7,562
Pimecrolimus27$3,660
Desonide74$3,184
Metronidazole38$3,109
Dutasteride69$2,851
Mometasone Furoate77$2,026
Clobetasol Propionate62$1,995
Ketoconazole86$1,880
Imiquimod43$1,258
Doxycycline Hyclate55$888
Minoxidil39$883
Levocetirizine Dihydrochloride59$832
Betamethasone Diprop AugmentedBetamethasone/Propylene Glyc12$636
Terbinafine Hcl13$219
Mupirocin23$214

Paid to pharmacies, not to this prescriber.

Other dermatology in San Juan

See the full list for Puerto Rico

Where these figures come from

Is this you, or does something look wrong? →